Monotard was Novo Nordisk's Euro brand name for their U100 lente-type insulin which is intermediate-acting. As of early 2006, this insulin was discontinued. It was known asNovolin L in North America; Eli Lilly made a comparable product, Humulin L, discontinued in the EU/UK in July 2004, also discontinued in North America in July 2005. Like all Lente insulins, regardless of species or strength, Monotard was a suspension of crystalline (ultralente) and amorphous (semilente) insulin in a ratio of 7 crystalline parts to 3 amorphous parts.
Attributes | Values |
---|---|
rdfs:label |
|
rdfs:comment |
|
Strength |
|
openedlife |
|
penlife |
|
dogaction |
|
handlingnotes |
|
mfg | |
shelflife |
|
cloudyorsoluble |
|
cataction |
|
generic | |
dcterms:subject | |
Origin | |
Name |
|
Similar | |
dbkwik:petdiabetes...iPageUsesTemplate | |
Line | |
Aliases | |
fgcolor |
|
BGCOLOR |
|
Action | |
Suspension | |
abstract |
|
is Aliases of |